Juvenile syndecan-1 null mice are protected from carcinogen-induced tumor development
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
We previously showed that mice with a null mutation in syndecan-1 (Sdc1; CD138) were resistant to Wnt1-induced mammary tumor initiation. The absence of Sdc1 inhibited the increase in the mammary stem cell fraction that is characteristic of preneoplasia in this model. As the tumor precursor cells are recruited from the stem/progenitor cell compartment, tumor development was also inhibited (Liu et al., 2004; PNAS 101, 4158). Although Sdc1-/- mice are grossly normal, they are systemically smaller, suggesting that developmental abnormalities may extend further than their mammary glands. We have therefore evaluated the multi-organ response of Sdc1-/- mice to carcinogen-induced tumor development (7,12-dimethylbenz[a]anthracene, DMBA), and find these mice to be resistant to tumorigenesis in all the predominant carcinogen-susceptible lineages. Thus, Sdc1-/- mice administered DMBA during juvenile development are resistant not only to epithelial tumors, including liver (60-80%) and lung tumors (C57BL6 mice, 60-80%), but also to lymphoma (over 70%, depending upon strain and carcinogen dose). We demonstrate that CD138 is expressed (heterogeneously) in the hematopoietic stem cell fraction (and not only in pre-B and plasma cells), and that tumors arise in both myeloid and lymphoid lineages. Furthermore, carcinogen-induced mammary tumors are bilineal, implying a bipotent precursor cell. Both observations imply that the DMBA-induced tumor precursor cells are drawn from the stem/progenitor fr…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, SDC1 is localized to the cell surface and is dispensable for normal tissue homeostasis.33”
From Therapeutic targeting of syndecan-1 axis overcomes acquired resistance to KRAS-targeted therapy in gastrointestinal cancers (2025) · cites this paper as [33]
Citations
Cites
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370 · cited 1×
“Tumor stem cells (observed in breast, neural and hematopoietic tumors; (Al-Hajj et al., 2003; Singh et al., 2003, 2004; Huntly and Gilliland, 2005) possess features in common with normal stem cells, although there is no direct proof of their recruitment from somatic stem cell compartments, nor are…”
BackgroundIdentification of human brain tumour initiating cells
Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,433 · cited 1×
“Tumor stem cells (observed in breast, neural and hematopoietic tumors; (Al-Hajj et al., 2003; Singh et al., 2003, 2004; Huntly and Gilliland, 2005) possess features in common with normal stem cells, although there is no direct proof of their recruitment from somatic stem cell compartments, nor are…”
BackgroundFunctions of Cell Surface Heparan Sulfate Proteoglycans
Bernfield, M., Götte, M., Park, P. W., Reizes, O., Fitzgerald, M. L., Lincecum, J., & Zako, M. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.729 · Cited by 2,688 · cited 3×
“Its function in vitro appears to be dominated by the heparan sulfate side chains, which participate in growth factor signaling by promoting ligand/receptor complex formation (Bernfield et al., 1999; Whitelock and Iozzo, 2005).”
BackgroundMorrison, S. J., & Weissman, I. L. (1994) · Immunity · doi:10.1016/1074-7613(94)90037-x · Cited by 1,115 · cited 2×
“1lo) (Morrison and Weissman, 1994) do not have self-renewal capacity and are similar to the ST-HSC/MPP population.”
BackgroundTaylor, K. R., & Gallo, R. L. (2006) · The FASEB Journal · doi:10.1096/fj.05-4682rev · Cited by 639 · cited 1×
“…during development, Sdc1 / mice are viable and fertile, although their pathologic responses are affected, including those involved in skin wound healing, microbial pathogenesis in the lung and leukocyte adhesion (Park et al., 2001; Gotte et al., 2002; Stepp et al., 2002; Taylor and Gallo, 2006).”
BackgroundLi, Y., Welm, B., Podsypanina, K., Huang, S., Chamorro, M., Zhang, X., Rowlands, T., Egeblad, M., Cowin, P., Werb, Z., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2136825100 · Cited by 521 · cited 1×
“In this case, the tumor precursor cell is recruited from these stem/progenitor cells (Li et al., 2003), and in Sdc1 / mice, subsequent tumorigenesis is inhibited.”
BackgroundCardiff, R. D., Anver, M. R., Gusterson, B. A., Hennighausen, L., Jensen, R. A., Merino, M. J., Rehm, S., Russo, J., Tavassoli, F. A., Wakefield, L. M., et al. (2000) · Oncogene · doi:10.1038/sj.onc.1203277 · Cited by 489 · cited 1×
“Samples were paraformaldehyde-fixed and paraffin-embedded for histopathological evaluation (Cardiff et al., 2000).”
MethodLeukaemia stem cells and the evolution of cancer-stem-cell research
Huntly, B. J. P., & Gilliland, D. G. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1592 · Cited by 483 · cited 1×
“Tumor stem cells (observed in breast, neural and hematopoietic tumors; (Al-Hajj et al., 2003; Singh et al., 2003, 2004; Huntly and Gilliland, 2005) possess features in common with normal stem cells, although there is no direct proof of their recruitment from somatic stem cell compartments, nor are…”
BackgroundHeparan Sulfate: A Complex Polymer Charged with Biological Activity
Whitelock, J. M., & Iozzo, R. V. (2005) · Chemical Reviews · doi:10.1021/cr010213m · Cited by 410 · cited 2×
“Its function in vitro appears to be dominated by the heparan sulfate side chains, which participate in growth factor signaling by promoting ligand/receptor complex formation (Bernfield et al., 1999; Whitelock and Iozzo, 2005).”
BackgroundClassification of Proliferative Pulmonary Lesions of the Mouse
Nikitin, A. Y., Alcaraz, A., Anver, M. R., Bronson, R. T., Cardiff, R. D., Dixon, D., Fraire, A. E., Gabrielson, E. W., Gunning, W. T., Haines, D. C., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3376 · Cited by 334 · cited 2×
“(Hy, by the criteria of Nikitin et al. (2004); examples shown below),”
Background
Cited by
Sarrazin, S., Lamanna, W. C., & Esko, J. D. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004952 · Cited by 1,516
“2009); juvenile mice resistant to carcinogen-induced tumorigenesis (McDermott et al. 2007); increased basal protein leakage and more susceptible to protein loss induced by combinations of IFN-g, TNF-a, and increased venous pressure (Bode et al.”
BackgroundAligned Collagen Is a Prognostic Signature for Survival in Human Breast Carcinoma
Conklin, M. W., Eickhoff, J. C., Riching, K. M., Pehlke, C. A., Eliceiri, K. W., Provenzano, P. P., Friedl, A., & Keely, P. J. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2010.11.076 · Cited by 1,285
Proteoglycans in cancer biology, tumour microenvironment and angiogenesis
Iozzo, R. V., & Sanderson, R. D. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01236.x · Cited by 569
“Further studies probing the mechanism of syndecan-1 activity in tumorigenesis indicate that the proteoglycan may be required for the activation of tumour precursor cells that arise within the stem/progenitor cell compartment [121, 122].”
BackgroundIbrahim, S. A., Gadalla, R., El-Ghonaimy, E. A., Samir, O., Mohamed, H. T., Hassan, H., Greve, B., El-Shinawi, M., Mohamed, M. M., & Götte, M. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0621-z · Cited by 270
“[16], and in Syndecan-1- knockout mice [29, 30].”
The signaling mechanisms of syndecan heparan sulfate proteoglycans
Lambaerts, K., Wilcox-Adelman, S. A., & Zimmermann, P. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.05.002 · Cited by 199
“(2) DNA uptake relies on HSPGs, lipid rafts and macropinocytosis but is independent of clathrin, dynamin and caveolin-1 [52].”
The heparanome—The enigma of encoding and decoding heparan sulfate sulfation
Lamanna, W. C., Kalus, I., Padva, M., Baldwin, R. J., Merry, C. L. R., & Dierks, T. (2007) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2007.01.022 · Cited by 179
Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression
Nikolova, V., Koo, C.-Y., Ibrahim, S. A., Wang, Z., Spillmann, D., Dreier, R., Kelsch, R., Fischgräbe, J., Smollich, M., Rossi, L. H., et al. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp001 · Cited by 183
Keely, P. J. (2011) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-011-9226-0 · Cited by 158
“The role of Sdc-1 is complex, however, as it has also been reported that Sdc-1 loss is associated with a decrease in mammary carcinogenesis in rodent models [63].”
Ibrahim, S., Yip, G. W., Stock, C. M., Pan, J., Neubauer, C., Poeter, M., Pupjalis, D., Koo, C.-Y., Kelsch, R., Schüle, R., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27629 · Cited by 167
“The striking resistance of syndecan-1-deficient mice to mammary tumorigenesis has been linked to a potential role in cancer stem cell function.(6) Stromal syndecan-1 is significantly downregulated upon preoperative systemic therapy of breast cancer,(7) consistent with a possible predictive value in neoadjuvant chemoth…”
BackgroundIbrahim, S. A., Hassan, H., Vilardo, L., Kumar, S. K., Kumar, A. V., Kelsch, R., Schneider, C., Kiesel, L., Eich, H. T., Zucchi, I., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0085737 · Cited by 120
“These findings mark Syndecan-1 as an important contributor to CSC stemness, and are in accordance with the observed upregulation of Syndecan-1 in breast cancer [34,35] and resistance of Syndecan-1-deficient mice to experimentallyinduced breast cancer [36-38]: CSCs are thought to be enriched in the SP, which is respons…”
BackgroundResultSyndecan-1 Is Required to Maintain Intradermal Fat and Prevent Cold Stress
Kasza, I., Suh, Y., Wollny, D., Clark, R. J., Roopra, A., Colman, R. J., MacDougald, O. A., Shedd, T. A., Nelson, D. W., Yen, M.-I., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004514 · Cited by 107
“Mice, diet and metabolic cage measurements The generation of Sdc12/2 mice has been described previously (McDermott et al 2007).”
BackgroundMethodInfluentialSelf-citationVitale, D. L., Katakam, S. K., Greve, B., Jang, B., Oh, E., Alaniz, L. D., & Götte, M. (2019) · FEBS Journal · doi:10.1111/febs.14967 · Cited by 125
Role of cell surface proteoglycans in cancer immunotherapy
Espinoza‐Sánchez, N. A., & Götte, M. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.07.012 · Cited by 122
Multifunctionality of extracellular and cell surface heparan sulfate proteoglycans
Kirn‐Safran, C. B., Farach‐Carson, M. C., & Carson, D. D. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0096-1 · Cited by 113
“Recently, the tumor protective effect of Sdc1 deficiency was confirmed by evaluating the potential of multiple organs including liver and lung to develop carcinogen-induced tumors [104].”
BackgroundThe extracellular matrix of hematopoietic stem cell niches
Lee‐Thedieck, C., Schertl, P., & Klein, G. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114069 · Cited by 104
Hashimoto, Y., Skacel, M., & Adams, J. C. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-185 · Cited by 80
“Syndecan-1 null mice are resistant to Wnt1activated mammary tumors and carcinogen-induced tumor development and have increased susceptibility to allergen-induced airway inflammation [5-7].”
BackgroundLiakou, E., Mavrogonatou, E., Pratsinis, H., Rizou, S., Evangelou, K., Panagiotou, P. N., Karamanos, N. K., Gorgoulis, V. G., & Kletsas, D. (2016) · Aging · doi:10.18632/aging.100989 · Cited by 72
“In this direction, mice with a null mutation in SDC1 are protected from carcinogen-induced tumor development [63].”
The endothelial glycocalyx anchors von Willebrand factor fibers to the vascular endothelium
Kalagara, T., Moutsis, T., Yang, Y., Pappelbaum, K., Farken, A., Cladder-Micus, L., Vidal‐y‐Sy, S., John, A., Bauer, A. T., Moerschbacher, B. M., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2017013995 · Cited by 72
Stepp, M. A., Liu, Y., Pal‐Ghosh, S., Jurjus, R. A., Tadvalkar, G., Sekaran, A., LoSicco, K., Jiang, L., Larsen, M., Li, L., et al. (2007) · Journal of Cell Science · doi:10.1242/jcs.03480 · Cited by 68
“, 2002); mice have been backcrossed into a Balb/C genetic background (McDermott et al., 2007; Alexander et al., 2000).”
BackgroundMethodWang, Q., Yang, L., Alexander, C. M., & Temple, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042883 · Cited by 70
“Like Sdc1 knockout mice, CASK mutant mice are smaller than normal [31,44].”
BackgroundSelf-citationRole of the Heparan Sulfate Proteoglycan Syndecan-1 (CD138) in Delayed-Type Hypersensitivity
Masouleh, B. K., ten Dam, G. B., Wild, M. K., Seelige, R., van der Vlag, J., Rops, A. L. W. M. M., Echtermeyer, F. G., Vestweber, D., Kuppevelt, T. H. V., Kiesel, L., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0800574 · Cited by 63
“In the adult, Sdc-1 is expressed in epithelia, endothelia, and several leukocyte subgroups including pre-B cells and plasma cells, macrophages, and hematopoietic stem cells (7, 17, 19).”
BackgroundMicro RNA regulation of proteoglycan function in cancer
Ibrahim, S., Hassan, H., & Götte, M. (2014) · FEBS Journal · doi:10.1111/febs.13026 · Cited by 66
Zhang, X., Wu, C., Song, J., Götte, M., & Sorokin, L. M. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300931 · Cited by 63
Syndecan-1 induction in lung microenvironment supports the establishment of breast tumor metastases
Chute, C. L., Yang, X., Meyer, K. K., Yang, N., O’Neil, K., Kasza, I., Eliceiri, K. W., Alexander, C. M., & Friedl, A. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-0995-x · Cited by 58
Self-citationAdhesion Deregulation in Acute Myeloid Leukaemia
Gruszka, A., Valli, D., Restelli, C., & Alcalay, M. (2019) · Cells · doi:10.3390/cells8010066 · Cited by 59
“Other types of AMs expressed by HSCs include sialomucins such as CD34, CD45R, CD43, CD162 (also known as the P-selectin glycoprotein ligand 1), and CD164 [21], as well as the CD44 [22] and syndecan-1 [23] proteoglycans (Figure 1, Table 1).”
BackgroundThe Role for Decorin in Delayed-Type Hypersensitivity
Seidler, D. G., Mohamed, N. A. E., Bocian, C., Stadtmann, A., Hermann, S., Schäfers, K. P., Schäfers, M. A., Iozzo, R. V., Zarbock, A., & Götte, M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100373 · Cited by 54
“(4, 37, 38), Sdc1 is highly expressed in the epidermis.”
BackgroundFGF signaling sustains the odontogenic fate of dental mesenchyme by suppressing β-catenin signaling
Liu, C., Gu, S., Sun, C., Ye, W., Song, Z., Zhang, Y., & Chen, Y. (2013) · Development · doi:10.1242/dev.097733 · Cited by 52
“The requirement of syndecan 1 for FGF signaling has been reported in mammalian cortical development, epithelial-mesenchymal transition and tumorigenesis (Stepp et al., 2002; McDermott et al., 2007; Wang et al., 2012).”
BackgroundHeparan Sulfate Proteoglycans: Key Mediators of Stem Cell Function
Ravikumar, M., Smith, R. A. A., Nurcombe, V., & Cool, S. M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.581213 · Cited by 51
Baston-Büst, D. M., Götte, M., Janni, W. J., Krüssel, J.-S., & Hess, A. P. (2010) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-8-133 · Cited by 44
“The recent observation that newborn Sdc-1 deficient mice are systemically smaller than their wild-type littermates suggests an important role for Sdc-1 during embryonic development [26].”
BackgroundRoss-Munro, E., Kwa, F. A. A., Kreiner, J., Khore, M., Miller, S., Tolcos, M., Fleiss, B., & Walker, D. W. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.568814 · Cited by 44
Antithetic roles of proteoglycans in cancer
Garusi, E., Rossi, S., & Perris, R. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0816-1 · Cited by 46
“Mice harboring deletion of the syndecan1 gene were originally found to be refractory to Wnt-1induced mammary carcinoma formation [46] and were subsequently discovered to be resistant to a variety of solid and hematopoietic tumors induced by treatment with carcinogens [47].”
BackgroundInvolvement of Syndecan-1 and Heparanase in Cancer and Inflammation
Teixeira, F. C. O. B., & Götte, M. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-34521-1_4 · Cited by 39
Pal‐Ghosh, S., Tadvalkar, G., & Stepp, M. A. (2017) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-21531 · Cited by 32
Thermogenic profiling using magnetic resonance imaging of dermal and other adipose tissues
Kasza, I., Hernando, D., Roldán‐Alzate, A., Alexander, C. M., & Reeder, S. B. (2016) · JCI Insight · doi:10.1172/jci.insight.87146 · Cited by 32
“BALB/cJ Sdc1–/– mice have been described previously (4, 44); at the time of study, the control BALB/cJ mice and Sdc1–/– BALB/cJ mice were age-matched and 8–10 weeks old.”
MethodSelf-citationPasqualon, T., Pruessmeyer, J., Jankowski, V., Babendreyer, A., Groth, E., Schumacher, J., Koenen, A., Weidenfeld, S., Schwarz, N., Denecke, B., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5174 · Cited by 30
“Syndecan-1 deficient mice were found to develop less lung tumors when treated with carcinogens [36].”
BackgroundJurjus, R. A., Liu, Y., Pal‐Ghosh, S., Tadvalkar, G., & Stepp, M. A. (2008) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2008.00423.x · Cited by 28
Loss of syndecan‐1 is associated with malignant conversion in skin carcinogenesis
Stepp, M. A., Pal‐Ghosh, S., Tadvalkar, G., Rajjoub, L. Z., Jurjus, R. A., Gerdes, M., Ryscavage, A. O., Cataisson, C., Shukla, A., & Yuspa, S. H. (2010) · Molecular Carcinogenesis · doi:10.1002/mc.20609 · Cited by 27
Characterization of receptors for murine pregnancy specific glycoproteins 17 and 23
Sulkowski, G. N., Warren, J., Ha, C. T., & Dveksler, G. S. (2011) · Placenta · doi:10.1016/j.placenta.2011.05.008 · Cited by 25
“5 pregnant uteri [29] and syndecan 1-null embryos are smaller than their wild type siblings [30].”
Evaporative cooling provides a major metabolic energy sink
Kasza, I., Adler, D., Nelson, D. W., Yen, C.-L., Dumas, S. N., Ntambi, J. M., MacDougald, O. A., Hernando, D., Porter, W. P., Best, F. A., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.06.023 · Cited by 25
“These mice show thin dWAT and are cold-stressed; they are also tumor resistant [25,33].”
BackgroundSelf-citationGlycans in Diseases and Therapeutics
Pavão, M. S. G. (2011) · Springer eBooks · doi:10.1007/978-3-642-16833-8 · Cited by 23
Staupe, R. P., Lodge, K. E., Thambi, N., Toole, D., Tamburino, A. M., Chang, D., Howell, B. J., Hazuda, D. J., Vora, K. A., & Sullivan, N. (2022) · Communications Biology · doi:10.1038/s42003-022-04216-9 · Cited by 14
“CD138 is also expressed on hematopoietic progenitors in the BM and additional markers with or without CD138 may add con fi dence in identifying LLPC within this tissue compartment 39 .”
Schmedt, A., Götte, M., Heinig, J., Kiesel, L., Klockenbusch, W., & Steinhard, J. (2012) · Prenatal Diagnosis · doi:10.1002/pd.2908 · Cited by 16
“This view is supported by two recent studies in animal models: Sdc1-deficient mice were shown to be systemically smaller both at embryonic development and at birth compared with their wild-type littermates.(21) In addition, two Sdc1 gene polymorphisms were shown to be associated with birth weight and body length in ca…”
ResultA Phenotypic Mouse Model of Basaloid Breast Tumors
Kim, S., Roopra, A., & Alexander, C. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030979 · Cited by 14
Self-citationHuang, Y., Jiang, W., Wang, Y., Zheng, Y., Cong, Q., & Xu, C. (2012) · Journal of Ovarian Research · doi:10.1186/1757-2215-5-21 · Cited by 14
“In one study, C57BL6 mice received daily doses of DMBA by gavage for 3 wk; 71% of animals developed granulosa cell tumors after one year [20].”
BackgroundEndometrial Cells Get Side-Tracked
Götte, M. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090775 · Cited by 11
Zhao, B., Xu, Y., Zhao, Y., Shen, S., & Sun, Q. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00856 · Cited by 13
“SDC1 (syndecan-1, CD138) is an abundant heparan sulfate proteoglycan expressed by most epithelial cells (26).”
BackgroundWang, Q., Yang, L., Alexander, C. M., & Temple, S. (2012) · PLoS ONE · doi:10.1371/annotation/76cf3bd3-f842-489f-8ad2-4c016447b84c · Cited by 9
Self-citationDiverse functions of uterine proteoglycans in human reproduction (Review)
Kitaya, K. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2012.826 · Cited by 8
“In support of this finding, mice lacking the syndecan-1 gene are fertile but exhibit fetal growth restriction which is frequently complicated with pre-eclampsia (54,55).”
BackgroundKlein, K., Hölzemer, A., Wang, T., Kim, T., Dugan, H. L., Jost, S., Altfeld, M. A., & García-Beltrán, W. F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.798235 · Cited by 7
“One of the most abundant GAGs is heparan sulfate, which is made by every cell in the body and plays a multitude of biological roles [reviewed in (6)] including wound repair (7, 8), tumorigenesis (9), cell adhesion and migration (10), signaling of growth factors (11, 12) and cytokines (13, 14), and host defense (15).”
BackgroundTheardy, M. S., Takeda, M., Sorokin, A., Chen, S., Yang, Z., Wang, X., Kanikarla, P., Coker, O., Nguyen, P., Wei, Y., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102253 · Cited by 6
Sanderson, R. D., Yang, Y., Purushothaman, A., Khotskaya, Y. B., Ritchie, J. P., & Ramani, V. C. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0814-8_9 · Cited by 7
Metabolic and behavioral parameters of mice with reduced expression of Syndecan-1
Gougoula, C., Bielfeld, A. P., Pour, S. J., Sager, M., Krüssel, J.-S., Benten, W. P. M., & Baston-Büst, D. M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0219604 · Cited by 4
(2024) · International Journal of Veterinary Science · doi:10.47278/journal.ijvs/2024.201 · Cited by 2
Role of Syndecan-1 in Cancer Stem Cells
Ibrahim, S., Hassan, H., Reinbold, R. A., Espinoza‐Sánchez, N. A., Greve, B., & Götte, M. (2021) · Biology of extracellular matrix · doi:10.1007/978-3-030-73453-4_12 · Cited by 2
Heparan Sulfate Proteoglycans in Cancer Therapy
Gassar, E. S., Ibrahim, S., & Götte, M. (2011) · Springer eBooks · doi:10.1007/978-3-642-16833-8_6 · Cited by 1
Ovarian Cancer Animal Models for Preclinical Studies and Development of Ovarian Cancer Drugs
Sandhiutami, N. M. D., Wuyung, P. E., Arozal, W., Louisa, M., & Rahmat, D. (2019) · JURNAL ILMU KEFARMASIAN INDONESIA · doi:10.35814/jifi.v17i2.734 · Cited by 1
Adrenals around Carcinogen Containing Implants suppress Tumorigenesis
Mesila, I. (2007) · DSpace repository (University of Tartu)
FGF signaling sustains the odontogenic fate of dental mesenchyme by suppressing β-catenin signaling
Liu, C., Gu, S., Sun, C., Ye, W., Song, Z., Zhang, Y., & Chen, Y. (2013) · Journal of Cell Science · doi:10.1242/jcs.143891
Notch Regulation in Breast Cancer
Izrailit, J. (2015) · TSpace (University of Toronto)
Implications of Stem Cell Growth Regulation for Breast Cancer
Alexander, C. M. (2007) · Defense Technical Information Center (DTIC) · doi:10.21236/ada474690
Self-citationModulation of Heparan Sulfate Proteoglycans During Herpes Simplex Virus Type-1 Infection
Karasneh, G. A. (2012) · Figshare
Metadata
- Authors
- McDermott, S. P., Ranheim, E. A., Leatherberry, V. S., Khwaja, S. S., Klos, K. S., & Alexander, C. M.
- Affiliations
- University of Wisconsin–Madison (US)
- Corresponding author
- Alexander, C M
- Venue
- Oncogene
- Published
- 2006-09-04
- Volume
- 26
- Issue
- 10
- Pages
- 1407-1416
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2076413581
- Cited by
- 61
- References
- 38
- Citations by year
- 2025: 1 · 2024: 1 · 2022: 1 · 2021: 3 · 2020: 4 · 2019: 6 · 2018: 2 · 2017: 2 · 2016: 2 · 2015: 2 · 2014: 2 · 2013: 4 · 2012: 8
- FWCI
- 1.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (T32-CA09135, T32CA009135, R01CA090877, CA 90877)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- syndecan-1, DMBA-induced carcinogenesis, tumor resistance, mammary tumors, liver tumors, lung cancer, lymphoma, hematopoietic stem cells, stem/progenitor cells, juvenile development
- MeSH terms
- Age Factors, Animals, Carcinogens, Female, Male, Mice, Inbred BALB C, Mice, Inbred C57BL, Neoplasms, Experimental, 9,10-Dimethyl-1,2-benzanthracene, Mice, Knockout, Body Size, Mice, Syndecan-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.